QID 377634

Date Published: 2022-10-13

QID 377634: vm2 NPM Package Remote Code Execution (RCE) Vulnerability (GHSA-mrgp-mrhc-5jrq) (Sandbreak)

vm2 is a sandbox that can run untrusted code with whitelisted Node's built-in modules. In versions prior to version 3.9.11, a threat actor can bypass the sandbox protections to gain remote code execution rights on the host running the sandbox. This vulnerability was patched in the release of version 3.9.11 of vm2.

Affected Versions:
VM2 versions prior to version 3.9.11

QID Detection Logic (Authenticated):
This QID checks for vulnerable version of vm2 npm package installed globally. The QID runs the "npm list -g --silent" command and checks the file "/usr/local/lib/node_modules/vm2/package.json" to look for vulnerable versions of vm2.

Note:
NPM packages can be installed anywhere as a developer/production dependency. This QID can only detect vm2 packages that are installed globally. For Microsoft Windows, this QID checks for installed packages within the '%systemdrive%\Users\Administrator' directory.

Successful exploitation of the vulnerability may result in remote code execution.

CVSS V3 rated as Critical - 10 severity.

CVSS V2 rated as Critical - 10 severity.

Solution

Customers are advised to update to version 3.9.11 or later. For more information please refer to Vendor Advisory

Vendor References

Github Advisory - github.com/patriksimek/vm2/security/advisories/GHSA-mrgp-mrhc-5jrq

CVEs related to QID 377634

CVE-2022-36067 |

Software Advisories

Advisory ID	Software	Component	Link
NA			www.npmjs.com/package/vm2/v/3.9.11

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].